论文部分内容阅读
充血性心力衰竭(下简称心衰)是心血管临床常见的急重症。据Framingham的调查,心衰的年发病率男性为2.3‰,女性为1.4‰,前者5年生存率仅50%。近十多年在心肌生化代谢、收缩生理以及血流动力学方面的研究进展,使人们对心衰的病生机制有了新的认识。各种新型药物研制成功并投入临床
Congestive heart failure (hereinafter referred to as heart failure) is a common acute cardiovascular disease. According to Framingham’s survey, the annual incidence of heart failure was 2.3 per 1,000 men and 1.4 per 1,000 females, with a 5-year survival rate of only 50%. Nearly a decade of myocardial biochemical metabolism, systolic physiology and hemodynamic research, so that people have a new understanding of the pathogenesis of heart failure. A variety of new drugs developed successfully and put into clinical practice